Foundation Medicine has partnered with Celgene to supply the company with its genetic tests for cancer. Under the deal, Celgene will use the tests to look at the genetic traits of patients enrolled in clinical trials of drugs for various diseases, such as multiple myeloma and prostate cancer.

Related Summaries